169354 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors; Neurotransmitters Dopamine
GENETICALLY ENCODED BIOLUMINESCENT SENSORS
#2CHEMICAL SENSORS EMPLOYING pH-SENSITIVE APTAMERS
#3G-PROTEIN COUPLED RECEPTOR ASSAY
#4MARKER AND DEVICE FOR DIAGNOSING OVERALL HEALTH STATUS OF INDIVIDUAL
#5PREDICTION OF AMOUNT OF IN VIVO DOPAMINE ETC., AND APPLICATION THEREOF
#6Non-enzymatic electrochemical sensor for measuring analytes
#7NEUROTRANSMITTER CONCENTRATION MEASURING APPARATUS FOR PROVIDING SECOND DERIVATIVE-BASED NEUROTRANSMITTER CONCENTRATION MEASUREMENT RESULT OF FAST-SCAN CYCLIC VOLTAMMETRY DATA AND METHOD THEREOF
#8BIOSENSORS FOR DETECTING CHANGES IN THE LEVEL OF A NEUROTRANSMITTER IN THE CENTRAL NERVOUS SYSTEM
#9GOLD NONOCLUSTERS, DOPAMINE BIOSENSORS INCLUDING THEM, AND METHODS FOR DIAGNOSING NEUROLOGICAL DISEASES USING THE SAME
#10DNA aptamer-cyanine complexes as mephedrone and cannabinoid colorimetric sensors
#11CATECHOLAMINE CONCENTRATIONS IN A BLOOD SAMPLE AND ARTERIAL HYPERTENSION STATUS IN A SUBJECT FOR A DIFFERENTIAL DIAGNOSIS OF NEURODEGENERATIVE DISEASES INCLUDING ALZHEIMER'S DISEASE
#12Method for simultaneous analysis of neurotransmitters and their metabolites based on derivatization
#13Method of Performing Differential Diagnosis of Neurodegenerative Diseases in a Subject
#14RAPID POLYMERIZATION OF POLYPHENOLS
#15Method of Performing Differential Diagnosis of Neurodegenerative Diseases in a Subject
#16Red fluorescent protein-based biosensor for measuring activity of dopamine receptor D1
#17NON-ENZYMATIC ELECTROCHEMICAL SENSOR FOR MEASURING ANALYTES
#183D CELL CULTURE
#19Biosensor for multi-analyte characterization
#20Antibodies to paliperidone and use thereof
#21Oxidase activity of polymeric coated cerium oxide nano-particles
#22On-chip biosensors with nanometer scale glass-like carbon electrodes and improved adhesive coupling
#23On-chip biosensors with nanometer scale glass-like carbon electrodes and improved adhesive coupling
#24Biosensor for multi-analyte characterization
#25Method of treating a dopamine related disorder in a subject by administering levodopa, in combination with a dopamine decarboxylase inhibitor and a catechol-o-methyltransferase inhibitor
#26Electrochemical aptasensors with a gelatin B matrix
#27Metal oxide-based biocompatible hybrid sorbent for the extraction and enrichment of catecholamine neurotransmitters and related compounds, and method of synthesis
#28Non-enzymatic electrochemical sensor for measuring analytes
#29Fabrication of high aspect ratio tall free standing posts using carbon-nanotube (CNT) templated microfabrication
#30Near-infrared fluorescent sensors for biological amines
#31Antibodies to paliperidone and use thereof
#32Electrochemical aptasensors with a gelatin B matrix
#33MARKER FOR DEPRESSION, ASSAY METHOD, METHOD FOR DETERMINING DEPRESSION, SCREENING METHOD FOR ANTIDEPRESSANTS, AND KIT
#34METHODS OF DETERMINING LEVELS OF FREE AMINO ACIDS AND DIPEPTIDES AND DIAGNOSING ALZHEIMER'S DISEASE
#35Antibodies to paliperidone and use thereof
#36Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brain
#37Individual information determining method, individual information determining device, electronic apparatus, and individual information determining program
#38Methods for identifying and validating selective anti-cancer stem cell agents
#39Compositions and methods for modulating dopamine neurotransmission
#40METHOD FOR MULTIPLE QUANTIFICATION OF AMINO GROUP-CONTAINING NON-PEPTIDIC COMPOUND WITH HIGH EFFICIENCY AND HIGH SENSITIVITY AND KIT THEREFOR
#41Specific marker Lmx1a on dopaminergic neurons
#42Polypeptides that inhibit dopamine D2 receptor-DISC1 interaction and methods of use thereof
#43Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof
#44Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof
#45Methods of determining levels of free amino acids and dipeptides and diagnosing Alzheimer's disease
#46Compositions and methods for modulating dopamine neurotransmission
#47Utilization of shield effect for dopamine detection and reagent development
#48CHEMICAL MESSENGER SENSOR
#49ANALYSIS KIT COMPRISING AT LEAST TWO MOLECULARLY IMPRINTED POLYMERS AND AT LEAST ONE MARKER, AND METHOD OF ANALYSIS USING SAME
#50Luminescence assay using macrocyclic lanthanide (III) complexes
#51METHODS OF DIAGNOSIS AND TREATMENT OF EQUINE LAMINITIS AND CUSHING'S SYNDROME
#52Stable neural stem cell lines
#53ESSENTIAL TREMOR DIAGNOSTIC AND TREATMENT
#54COMBINATION OF A SEROTONIN REUPTAKE INHIBITOR AND A 5-HT2C ANTAGONIST, INVERSE AGONIST OR PARTIAL AGONIST
#55Method of measuring the activity of G(alpha)i- or G(alpha)o-coupled receptors using Ca influx in cells
#56PAR-4 RELATED METHODS AND COMPOSITIONS
#57METHODS FOR PROMOTING DOPAMINERGIC NEURONAL DEVELOPMENT BY USING NG4A-SUBFAMILY AND WNT-LIGANDS
#58Compositions and Methods For Modulating Dopamine Nerutransmission
#59Phosphodiesterase acitvity and regulation of phosphodiesterase 1-B-mediated signaling in brain
#60Specific marker Lmx1a on dopaminergic neurons
#61Ubiquitination of Membrane Transporters
#62Novel genes regulated in the developing human ventral mesencephalon
#63COMBINATION OF A SEROTONIN REUPTAKE INHIBITOR AND A 5-HT2C ANTAGONIST, INVERSE AGONIST OR PARTIAL AGONIST
#64Methods for the prediction of suicidality during treatment
#65Diagnostics and therapeutics for diseases associated with dopamine receptor d4 (drd4)
#66Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands
#67Methods for identifying compounds for regulating muscle mass or function using dopamine receptors
#68Method of measuring the activity of G(alpha)i- or G(alpha)o-coupled receptors using Ca2+ influx in cells
#69Mitigating symptoms and behaviors of substance abuse by modulating GDNF or BDNF pathway activity
#70Method of screening cocaine antagonists
#71Indium oxide doped zinc oxide decorated mesoporous carbon nanocomposite as a dopamine sensor